Loading
Only a handful of insider records exist for Aegerion Pharmaceuticals, Inc., the last one from 29 January 2016, too few to describe a trend. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
2 of 2 declarations
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on NASDAQ under the ticker AEGR.